Cargando…

Coronavirus Disease 2019 (COVID-19) and Transplantation: Pharmacotherapeutic Management of Immunosuppression Regimen

The 2019 novel coronavirus disease (COVID-19) was first detected in Wuhan, Hubei Province, China, in late 2019. Since then, COVID-19 has spread to more than 200 countries in the world, and a global pandemic has been declared by the World Health Organization (WHO). At present, no vaccines or therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mirjalili, Mahtabalsadat, Shafiekhani, Mojtaba, Vazin, Afsaneh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340365/ https://www.ncbi.nlm.nih.gov/pubmed/32694915 http://dx.doi.org/10.2147/TCRM.S256246

Ejemplares similares

Prevalence, Risk Factors And Treatment Of The Most Common Gram-Negative Bacterial Infections In Liver Transplant Recipients: A Review
por: Shafiekhani, Mojtaba, et al.
Publicado: (2019)

Psychotropic drug therapy in patients in the intensive care unit – usage, adverse effects, and drug interactions: a review
por: Shafiekhani, Mojtaba, et al.
Publicado: (2018)

Evaluation of aminoglycosides utilization in intensive care units of a teaching hospital in southern Iran
por: Vazin, Afsaneh, et al.
Publicado: (2019)

Pharmacological agents for the prevention of colistin-induced nephrotoxicity
por: Mirjalili, Mahtabalsadat, et al.
Publicado: (2022)

The effect of different intensivist staffing patterns on the rate of potential drug–drug interactions in adult trauma intensive care units
por: Masjedi, Mansoor, et al.
Publicado: (2020)

Comparison of Ceftizoxime Plus Ampicillin-Sulbactam versus Gentamicin Plus Ampicillin-Sulbactam in the Prevention of Post-Transplant Early Bacterial Infections in Liver Transplant Recipients: A Randomized Controlled Trial
por: Shafiekhani, Mojtaba, et al.
Publicado: (2020)

The effect of silymarin on liver enzymes and antioxidant status in trauma patients in the intensive care unit: a randomized double blinded placebo-controlled clinical trial
por: Mirzaei, Ehsan, et al.
Publicado: (2021)

Pharmacotherapeutic approach toward urological medications and vaccination during COVID-19: a narrative review
por: Shafiekhani, Mojtaba, et al.
Publicado: (2021)

Antibiotic stewardship implementation at the largest solid organ transplantation center in Asia: a retrospective cohort study
por: Shafiekhani, Mojtaba, et al.
Publicado: (2023)

Administration of COVID-19 vaccines in immunocompromised patients
por: Negahdaripour, Manica, et al.
Publicado: (2021)

Challenges in the Pharmacotherapeutic Management of Pediatric Asthma
por: Ioniuc, Ileana, et al.
Publicado: (2022)

Immunosuppressive and immunomodulatory therapies in dermatology and coronavirus disease 2019 (COVID-19)
por: Mansouri, Parvin, et al.
Publicado: (2021)

Pattern and associated factors of adherence to immunosuppressive medications in kidney transplant recipients at a referral center in Iran
por: Moradi, Omid, et al.
Publicado: (2019)

Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019
por: Sattui, Sebastian E., et al.
Publicado: (2023)

Tailoring management and immunosuppression regimen in kidney transplant recipients with COVID-19 infection: lessons from Singapore
por: Chang, Zi Yun, et al.
Publicado: (2021)

Coronavirus disease 2019 in heart transplant recipients: Risk factors, immunosuppression, and outcomes
por: Genuardi, Michael V., et al.
Publicado: (2021)

Association between Serum Vitamin D Concentration Status and Matrix Metalloproteinase-9 in Patients Undergoing Elective Percutaneous Coronary Intervention
por: Foroughinia, Farzaneh, et al.
Publicado: (2020)

Medical evaluation and pharmacotherapeutical strategies in management of urolithiasis
por: Ng, Derry Minyao, et al.
Publicado: (2021)

Pharmacotherapeutic targets in Alzheimer's disease
por: Biran, Yif'at, et al.
Publicado: (2009)

Quality of life associated with immunosuppressant treatment adherence in liver transplant recipients: A cross-sectional study
por: Shafiekhani, Mojtaba, et al.
Publicado: (2023)

Immunosuppressants: Coronavirus disease-2019: case report
Publicado: (2020)

Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies
por: Maan, Raoel, et al.
Publicado: (2015)

Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand?
por: Shafiekhani, Mojtaba, et al.
Publicado: (2021)

Review of available studies of the neurobiology and pharmacotherapeutic management of trichotillomania
por: Johnson, Jacklyn, et al.
Publicado: (2016)

Managing Severe Hemophilia A in Children: Pharmacotherapeutic Options
por: Regling, Katherine, et al.
Publicado: (2022)

Drug-related Problems in Solid-Organ Transplant Recipients Hospitalized for COVID-19: An Experience of a Referral Tertiary Center in Iran
por: Azadi, Soha, et al.
Publicado: (2022)

Patient involvement in selection of immunosuppressive regimen following transplantation
por: Popoola, Joyce, et al.
Publicado: (2014)

Transplantation: Polyomavirus Nephropathy and the Risk of Specific Immunosuppression Regimens
por: Wu, Christine, et al.
Publicado: (2006)

Traveling for heart transplantation and returning with COVID-19: a logistical, clinical, and pharmacotherapeutic challenge from the Middle East
por: Atallah, Bassam, et al.
Publicado: (2020)

Immunosuppressants: Coronavirus disease 2019: 4 case reports
Publicado: (2020)

Corticosteroids/immunosuppressants: Coronavirus disease 2019: case report
Publicado: (2020)

Immunosuppressants: Coronavirus disease of 2019: 3 case reports
Publicado: (2022)

Immunosuppressant Management in Renal Transplant Patients with COVID-19
por: Ahmadian, Elham, et al.
Publicado: (2021)

Phytochemical-Based Nano-Pharmacotherapeutics for Management of Burn Wound Healing
por: Qadir, Abdul, et al.
Publicado: (2021)

Immunosuppressive regimens on conversion of cytomegalovirus infection to disease in liver transplant recipients
por: Rabbani, Amirhassan, et al.
Publicado: (2022)

Longitudinal evaluation of the impact of immunosuppressive regimen on immune responses to COVID-19 vaccination in kidney transplant recipients
por: Wiedemann, Aurélie, et al.
Publicado: (2022)

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
por: Locke, Jayme E, et al.
Publicado: (2011)

Immune Targeted Therapies for COVID-19 Infection: A Narrative Review
por: Forouzani-Haghighi, Bahareh, et al.
Publicado: (2022)

Immunosuppressants: Lymphopenia, neutropenia and prolongation of the coronavirus disease 2019 (COVID-19) viral clearance: case report
Publicado: (2021)

The Future of Schizophrenia Pharmacotherapeutics: Not So Bleak
por: Carpenter, William T.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_a07te3j4l6odt3711tis875jgr